Table 1: The demographic and clinical features of the patients group.
| # | Age (years) Sex | Eye affected | VA at presentation | HVF (MD, dB): presentation | MRI CE | Diagnosis | Steroids | Interval* (month) | VA at test | HVF (MD, dB) at test: | CFF (Hz) |
| 1 | 66, F | OD | 20/40 | -30.65 | Y | folicular lymphoma | Y | 18 | 20/20 | -9.47 | 20.1 |
| OS | 20/60 | -31.11 | Y | Y | 20/25 | -11.46 | 20.3 | ||||
| 2 | 63, F | OD | 2/200 | 29.48 | Y | idiopathic | Y | 5 | 20/30 | -3.21 | 28.7 |
| 3 | 44, M | OD | 20/40 | -18.87 | Y | MS | Y | 14 | 20/20 | -3.09 | 31.9 |
| 4 | 40, F | OD | 20/20 | -15.04 | Y | idiopathic | Y | 3 | 20/20 | -0.79 | 13.2 |
| 5 | 48, M | OD | 20/20 | -24.29 | Y | idiopathic | Y | 24 | 20/20 | -2.03 | 12.6 |
| OS | 20/400 | -32.87 | Y | Y | 20/20 | -5.56 | 12.5 | ||||
| 6 | 47, F | OD | counting finger | -16.44 | Y | idiopathic | Y | 5 | 20/100 | -9.49 | 19.9 |
| 7 | 47, F | OD | severe | - | - | MS | Y | 204 | 20/20 | -3.50 | 22.9 |
| 8 | 33, F | OS | light perception | unable | Y | MS | Y | 16 | 20/800 | -20.68 | 11.2 |
| 9 | 36, F | OD | 20/200 | -33.86 | Y | MS | Y | 33 | 20/20 | -5.41 | 34.4 |
| 10 | 56, F | OD | 20/60 | -9.71 | Y | idiopathic | Y | 6 | 20/20 | -4.03 | 27 |
| OS | 20/30 | -2.61 | Y | Y | 20/20 | -0.88 | 26.9 | ||||
| 11 | 49, M | OD | hand motion | -26.84 | Y | idiopathic | Y | 48 | 20/25 | -20.22 | 29.6 |
#Patient number, *The interval between patient's initial presentation and the time of the study; -Unavailable; M: Male; F: Female; OD: Right eye; OS: Left eye; CE: Contrast enhancement of the optic nerve; MS: Multiple sclerosis; Idiopathic: Idiopathic optic neuritis.